Drugs that Target Cellular Signaling Pathways for Breast Cancer Treatment

Authors

  • Nadeem Kizilbash Department of Chemistry, Faculty of Physical Sciences, Quaid-i-Azam University, Islamabad-45320, Pakistan.
  • Marjan Assefi University of North Carolina at Greensboro, Greensboro, NC 27403, USA.
  • Naila Mahmood Molecular Immunology Laboratory, Atta-ur-Rehman School of Applied Biosciences, National University of Science and Technology, Islamabad, Pakistan.
  • Sohila Nankali Northcentral University, San Diego, CA, USA.
  • A. Nanklai Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Gholamreza Abdi Department of Biotechnology, Persian Gulf Research Institute, Bushehr, 75169, Iran.

DOI:

https://doi.org/10.9734/bpi/cpms/v6/3114B

Keywords:

Cellular signaling, breast cancer treatment, genetic mutations

Abstract

The identification of genetic mutations and the exploration of several cellular signaling pathways has led to the development of a number of molecular targeting agents, which can be targeted in several ailments for therapeutic basis. Recently, many drugs have been introduced to treat breast cancer. These drugs are administered either orally or via an injection. These drug delivery systems minimize toxicity and improve efficiency. These new drugs and delivery mechanisms have replaced the older cumbersome strategies and have helped the patients in several ways. They offer greater benefits to patients and have reduced side effects.

Published

2022-07-14

How to Cite

Nadeem Kizilbash, Marjan Assefi, Naila Mahmood, Sohila Nankali, A. Nanklai, & Gholamreza Abdi. (2022). Drugs that Target Cellular Signaling Pathways for Breast Cancer Treatment. Current Practice in Medical Science Vol. 6, 148–160. https://doi.org/10.9734/bpi/cpms/v6/3114B

Issue

Current Practice in Medical Science Vol. 6

Section

Chapters